Barrick Mining Corporation Stock Price, News & Analysis

Hexagon US Federal (HEXA) has announced the divestiture of its Strategic Services & Solutions (HS3) business to Bart & Associates (B&A), as initially disclosed on July 2, 2025. This strategic move aims to streamline operations and sharpen focus on the company's core technology offerings.

The company will concentrate on delivering cutting-edge software, hardware, and value-added products supporting defense, intelligence, and federal-civilian missions across public safety, geospatial-intelligence, sensors & systems, and position, navigation, and timing (PNT). The HS3 business, known for providing IT services, geospatial services, and integrated solutions, will continue its federal government support under B&A's ownership.

Barrick Mining Corporation (NYSE:B) is advancing its $2 billion Super Pit Expansion Project at the Lumwana mine in Zambia, transforming it into a Tier One copper mine. The expansion will double copper production to 240,000 tonnes annually, supported by a 50 million tonne per annum processing plant.

Since 2019, Lumwana has contributed over $4 billion to Zambia's economy through taxes, royalties, procurement, and wages, with 79% ($3.4 billion) spent with local suppliers. The project includes development of Manyama township, an industrial supplier park, and a new regional airstrip. The mine employs 98% Zambian nationals and is implementing a REDD+ forest conservation program covering 300,000 hectares.

The operation is tracking well against its 2025 production guidance, with strong Q1 performance driven by increased plant throughput and improved open-pit efficiency.

SimScale and Hexagon (HEXA) have announced the general availability of Marc nonlinear finite element analysis (FEA) solver technology on the SimScale cloud platform. This integration allows engineers and design teams to access Marc's advanced nonlinear simulation capabilities directly through web browsers.

The cloud-native solution offers key features including fast nonlinear analysis, real-time collaboration, AI-powered workflows, High Performance Computing (HPC) scalability, and comprehensive multi-physics coverage. The technology is immediately available to SimScale's 700,000 Community users for limited free, non-commercial testing.

Barrick Mining Corporation (NYSE:B) celebrates five years of its Twiga partnership with the Tanzanian government, demonstrating significant achievements in sustainable mining development. The company has injected $4.79 billion into Tanzania's economy, including $558 million in H1 2025.

Key operational highlights include over 90% procurement from Tanzanian suppliers and a 96% Tanzanian workforce. The partnership launched a $30 million Future Forward education programme with the government, expanding school infrastructure to accommodate 45,000 additional pupils. Both Bulyanhulu and North Mara mines are performing as planned, with significant infrastructure improvements and exploration activities targeting resource extensions.

Barrick Mining (NYSE:B) reports significant progress at Kibali, Africa's largest gold mine, with promising drilling results from the ARK-KCD corridor indicating potential for substantial reserve growth. The mine has surpassed $6.3 billion in DRC investment, including $3.1 billion to local contractors.

Operational highlights include the completion of a 16MW solar plant with Battery Energy Storage System, pushing renewable energy usage to 85%. The mine operates on 100% renewable energy for six months annually. The company is also advancing biodiversity initiatives, planning to introduce 64 additional white rhinos to Garamba National Park.

Community development continues with 41 of 44 projects completed through the 0.3% development fund, while $4.8 million has been invested in Cahier des Charges execution. The mine supports over 700 Congolese companies through procurement and capacity-building initiatives.

BioArctic (NASDAQ Stockholm: BIOA B) announced that its founder, Professor Lars Lannfelt, will receive the prestigious 2025 Hartwig Piepenbrock-DZNE Prize for his pioneering work in Alzheimer's disease research and the development of lecanemab.

Professor Lannfelt, who founded BioArctic in 2003 with Pär Gellerfors, made groundbreaking discoveries about the role of amyloid-beta protein in Alzheimer's disease. These findings led to the development of lecanemab, an antibody treatment that targets specific forms of amyloid-beta in the brain, developed in collaboration with Eisai. The treatment showed positive results in the global Phase 3 Clarity AD trial.

The award ceremony will take place in Bonn in November 2025. The prize, awarded biennially since 2011, recognizes outstanding research in neurodegenerative disorders.

Cree LED, a Penguin Solutions brand, has been awarded the ETQ Innovation Excellence Award 2025 for its innovative implementation of ETQ Reliance quality management system (QMS). The company developed two key solutions: a customer survey module providing instant access to satisfaction data, and a custom quoting solution that automates traditional manual processes.

The custom-built survey module integrates with ETQ Reliance to streamline document management and improve operational efficiency. Additionally, the automated quoting module eliminates manual calculations, reduces errors, and enables dynamic pricing based on customer history, market trends, production quantities, and inventory levels.

Barrick Mining Corporation is facing significant challenges in Mali as the Bamako Commercial Tribunal has placed its Loulo-Gounkoto complex under temporary provisional administration. The company has initiated arbitration through the International Centre for Settlement of Investment Disputes (ICSID) following the Malian government's actions to block gold exports and seize gold stocks. Several Barrick employees remain detained without clear justification. While Barrick maintains legal ownership of the mine, operational control has been transferred to an external administrator. Despite making good faith concessions, Barrick emphasizes it cannot accept terms that would compromise operational viability. The company, which has been operating in Mali for nearly 30 years, remains open to dialogue with the government while pursuing legal remedies through ICSID arbitration to protect its rights under binding Mining Conventions.

BioArctic announced positive interim safety results for exidavnemab in its Phase 2a EXIST study, enabling progression to higher dose cohorts. The study evaluates exidavnemab as a potential disease-modifying treatment for Parkinson's disease and Multiple System Atrophy (MSA). The first cohort demonstrated that the lower dose was safe and well-tolerated compared to placebo in Parkinson's patients. Two new cohorts will now evaluate higher doses in both Parkinson's and MSA patients. Exidavnemab, a monoclonal antibody, selectively targets pathological alpha-synuclein aggregates while preserving physiological forms. The drug has received orphan drug designation in the US and a positive opinion for orphan medicinal product designation in the EU for MSA treatment. The EXIST study is randomized, double-blinded, and placebo-controlled, evaluating safety, tolerability, pharmacokinetics, and various biomarkers.